Introduction: Social support has been linked to quitting smoking, but the mechanisms by which
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In addition to asking more refined questions about how social support works, it is also important to determine for whom it works best. Understanding who is most likely to benefit from social support will help tailor supportive interventions to individual needs and may improve the effectiveness of such treatments (Westmaas et al., 2010) . Personality is one factor that may moderate the stress-buffering effects of social support for smokers. For example, individuals higher in trait negative affectivity or neuroticism might gain more advantages from stressbuffering support than individuals lower in negative affectivity or neuroticism. Indeed, one study found that smokers with higher pretreatment negative affectivity benefited more from support counseling, while those with lower pretreatment negative affectivity benefited more from skills training (Zelman, Brandon, Jorenby, & Baker, 1992) . Given the importance of negative affectivity with both the beneficial effects of social support and the prediction of smoking relapse (Brandon, 1994) , we sought to test a moderated mediation model of stress-buffering, such that individuals high in negative affectivity would show the greatest stress-buffering effects of social support.
Specifically, in the current study, we aimed to test the stress-buffering model of social support by examining negative affect-related mediators linking social support to cessation outcomes in 349 women enrolled in a smoking cessation program who were followed-up for 12 months post treatment. Consistent with prior studies, we hypothesized that social support would be negatively associated with risk of relapse and that this effect would be mediated by reduced withdrawal symptoms, including negative affect, and depressive symptoms over time. Finally, we predicted that the personality trait of neuroticism, or negative affectivity (Watson & 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 at University of Pittsburgh on March 23, 2015 http://ntr.oxfordjournals.org/ Downloaded from A c c e p t e d M a n u s c r i p t Social Support, Relapse, and Negative Affect 6 Pennebaker, 1989), would moderate this effect (i.e., moderated mediation; Muller, Judd, & Yzerbyt, 2005) , such that individuals high in negative affectivity would show the greatest stressbuffering effects of social support. Because of evidence that perceived availability of social support, rather than mere membership in a social group or number of social contacts, is the critical determinant of stress buffering (Cohen & Wills, 1985; Mermelstein et al., 1986; Piasecki & Baker, 2001 ), we measured perceptions of available support in the current study.
Method

Participants and Design
We conducted secondary analyses using data from a randomized, double-blind, placebo- Participants were 349 female smokers between the ages of 18 and 65 years who were motivated to quit smoking, smoked a minimum of 10 cigarettes per day, and endorsed concern about post-cessation weight gain. Women were recruited using posters, advertisements, and mailings. Exclusion criteria included current major depressive disorder or suicidality, drug or 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   at University of Pittsburgh on March 23, 2015 http://ntr.oxfordjournals.org/ Downloaded from A c c e p t e d M a n u s c r i p t Social Support, Relapse, and Negative Affect 7 alcohol dependence within the past year, psychotic disorders as well as conditions associated with a lowered seizure threshold, the use of medications contraindicated with bupropion, uncontrolled hypertension, use of bupropion with the past year for more than 1 week, pregnancy or intention to become pregnant within the next year, and current use of other smoking or weight loss treatments. As reported previously (Levine et al., 2010) , there were no baseline differences in participant characteristics (i.e., age, education, race, weight, body mass index, cigarettes per day, and nicotine dependence) across the four treatment conditions.
Counseling and Study Medication
Counseling involved 12, 90-minute group sessions delivered over 3 months, by clinicians with Masters degrees, trained to adherence on a treatment manual. All participants received cessation counseling focused on preparing to quit, the benefits of cessation, coping with smoking urges, and relapse prevention. The weight concerns and standard treatment interventions differed only in the additional content related to weight concerns. Specifically, the concerns intervention sought to reduce concerns about post-cessation weight gain to promote smoking cessation. This therapy focused on restructuring thoughts about food, eating, and weight and reevaluating beliefs about the importance of a low weight and ideal shape. Sessions included education about cessation-related weight gain, the benefits of cessation relative to modest weight gain, and the disadvantages of trying to diet while quitting. The standard intervention did not directly address weight concerns. During these sessions, women were encouraged to discuss aspects of smoking cessation that related to their social situations (see Levine et al., 2010 for additional details). Study medication was initiated at the second treatment session and a target quit day (TQD) was set for 10 to 14 days later. Bupropion hydrochloride sustained release (150 mg), supplied by GlaxoSmithKline, or placebo was administered once daily for the first 2 days and twice daily for the remainder of the 26-week treatment.
Measures
Demographic information, smoking history, nicotine dependence, personality measures, and social support were collected prior to randomization. Assessments of smoking (i.e., biochemically-verified prolonged abstinence), withdrawal symptoms, and depression were assessed for three weeks before the TQD and at months 1, 3, 6, and 12 post TQD.
Nicotine Dependence. Nicotine dependence was assessed by the Fagerström Test for Nicotine Dependence (FTND; Heatherton, Kozlowski, Frecker, & Fagerström, 1991) .
Social Support. Perceived availability of social support was assessed by the Interpersonal Support Evaluation List (ISEL; Cohen, Mermelstein, Kamarck, & Hoberman, 1985) , which measures perceived availability of supportive functions across four specific domains: appraisal support (perceived availability of having someone to talk to about one's problems), belonging support (perceived availability of people with whom one can do things), tangible support (perceived availability of material aid), and self-esteem (perceived availability of a positive comparison when comparing one's self to others). The ISEL has excellent internal reliability, test-retest reliability, and construct validity (Cohen et al., 1985; Heitzmann & Kaplan, 1988) . Analyses focused on the ISEL total score, as well as the four domain scores. Smoking Abstinence. At each assessment, women were interviewed about smoking using the time-line follow-back method, which covered the interval since the last completed assessment (Brown, Burgess, Sales, Whitely, Evans, & Miller, 1998) . In addition, expired-air carbon monoxide (CO) was collected using a Vitalograph BreathCO monitor (Vitalograph Inc, Lenexa, Kansas) and salivary samples were collected to assess cotinine levels. A CO reading of 8 ppm or less and a cotinine level of less than 15 µg/L were used to confirm nonsmoking (SRNT Subcommittee on Biochemical Verification, 2002). Relapse was defined as the self-report of smoking for 7 consecutive days at any point after the TQD or any biochemical indication of smoking (Hughes, Keely, Niaura, Ossip-Klein, Richmond, & Swan, 2003) . Smoking for less than 7 days consecutively was not considered to be a relapse unless biochemical markers indicated smoking. Women who dropped out of treatment were considered to have relapsed as of the day following the last visit on which abstinence was verified. In cases when CO or cotinine measurement did not confirm abstinence or were not available, women were coded as having relapsed.
Withdrawal Symptoms. Withdrawal symptoms were assessed using visual analog scales ranging from 0 ("not at all") to 100 ("severe") for the following 12 symptoms of DSM-IV defined tobacco withdrawal: urge for cigarette, irritable/angry, anxious/tense, difficulty concentrating, restless, impatient, excessive hunger, depression, drowsiness, headache, stomach problems, insomnia. Participants were asked to rate how much they were experiencing each symptom "today". A composite score was calculated by taking an average of the 12 symptoms 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Depression Symptoms. The Beck Depression Inventory (BDI; Beck, Ward, Mendelson, Mock, & Erbaugh, 1961 ) was used to assess depressive symptoms during the previous week, and the total score from the three visits prior to TQD were averaged to create a pre-cessation baseline.
Statistical Analyses
A Cox model was used to examine the relationships between social support and risk of relapse, controlling for randomization groups FTND, and race (race was entered as a covariate because prior work revealed racial differences in perceived social support as assessed by the ISEL; e.g., Creswell, Wright, Troxel, Ferrell, Flory, & Manuck, in press). To examine the relationship between social support and withdrawal, mixed-effect models were applied to withdrawal symptoms from subjects who were abstinent at subsequent assessment points (1, 3, 6, 12 months), with a random subject-specific term and fixed terms of social support, pre-quit withdrawal symptoms, randomization groups, number of cigarettes smoked per day, and time.
Withdrawal was then entered into the Cox model as a time-varying covariate, along with social support, randomization groups, nicotine dependence, race, and number of cigarettes per day, to examine whether the effect of social support on relapse time was mediated by reduced withdrawal symptoms over time. These mediation analyses were then run separately for depressive symptoms. Finally, to determine whether individuals high in trait negative affectivity (neuroticism) would show the greatest stress-buffering effects of social support (i.e., moderated mediation), a mixed-effect and/or a Cox model was used to determine whether the indirect effect 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Results were unchanged, however, when including these 34 participants in analyses. Table 1 Table 2 displays withdrawal symptoms and depression scores across assessment sessions for participants who remained abstinent.
Results
Abstinence and Time to Relapse
Of the 349 women at baseline, 31.8%, 21.8%, and 16.3% met criteria for prolonged abstinence at 3, 6, and 12 months, respectively. The median time to relapse was 13 weeks. As reported previously, abstinence rates and time to relapse were significantly improved for women receiving both bupropion and weight concerns counseling (Levine et al., 2010) . 
Steps to Test the Stress-Buffering Model of Social Support
Step 1: Social Support as a Predictor of Risk of Relapse As predicted, after controlling for random assignment to bupropion vs. placebo and enhanced counseling vs. standard treatment conditions, FTND level, and race, the ISEL total score was negatively related to risk of relapse in a survival model, χ 2 (df = 1) = 6.63, p = 0.01, as were the subscales of tangible, χ 2 (df = 1) = 9.46, p = 0.002, and belonging support, χ 2 (df = 1) = 8.04, p = 0.005.
Step
2: Social Support as a Predictor of Withdrawal Symptoms and Depression over Time
After controlling for covariates, the ISEL total score was negatively related to withdrawal symptoms over time in mixed effects models, F (1, 94) = 5.08, p =.03, as were the ISEL subscales of appraisal, F (1, 94) = 6.15, p =.01, self-esteem, F (1, 87) = 7.77, p =.007, and belonging support, F (1, 94) = 3.83, p =.05. The ISEL total score was also negatively related to depressive symptoms over time in mixed-effects models, F (1, 83) = 11.39, p=.001, as were the ISEL subscales of appraisal, F (1, 87) = 14.21, p < .001, and belonging support, F (1, 78) = 12.94, p < .001.
Step 3 Mediation: Is the Relationship between Social Support and Risk of Relapse Mediated by Reductions in Withdrawal Symptoms and Depression over Time?
As hypothesized, a temporal mediation model showed that the effects of the ISEL total score, as well as the subscale of belonging support, on time to relapse were partially mediated by and the subscale of belonging support were considered here, as they were the only two social support variables that were significant in both step 1 and step 2 above. Contrary to predictions, depression symptoms did not mediate the relationship between social support and time to relapse.
Moderated Mediation: Do Individuals High in Trait Negative Affectivity Show the Greatest
Stress-Buffering Effects of Social Support?
The ISEL total score and the subscale of belonging support were considered in the moderated mediation analyses, as these were the two variables that were associated with both risk of relapse and withdrawal symptoms. Contrary to predictions, the effect of social support total score on withdrawal did not depend on neuroticism level, F (1, 233) = .01, p =.93, nor did the effect of withdrawal on relapse depend on neuroticism level, χ 2 (df = 1) = .67, p = .41.
Similarly, the effect of belonging social support on withdrawal did not interact with neuroticism level, F(1,233) = .27, p = .61, nor did the mediational effect of withdrawal depend on neuroticism level, χ 2 (df = 1) = .05, p = .83.
Discussion
Social support is an important predictor of smoking cessation success, but the mechanisms by which social support affects cessation are not well understood (Westmaas et al., 2010) . The current study revealed a stress-buffering effect of social support, in which perceived social support protected or "buffered" individuals from withdrawal symptoms related to quitting smoking. Specifically, we found that increased social support predicted both reduced severity of women from the harmful effects of cessation-related withdrawal symptoms, which in turn may relate to cessation success. These findings are consistent with the stress-buffering model, which states that social support helps smokers to quit and maintain abstinence by helping them to evaluate and deal more effectively with the stress associated with quitting smoking (Cohen, Gottlieb, & Underwood, 2000; Cohen & Wills, 1985; Cohen et al., 1988) .
Contrary to predictions, we did not find evidence of mediation by reduced symptoms of depression as assessed by the BDI, suggesting that social support may protect women from stress/negative affectivity related to withdrawal symptoms specifically, rather than depressive symptoms more generally. However, women with current major depressive disorder were excluded from this study, and participants did not report many depressive symptoms (mean BDI scores fell well within the "minimal depression" cutoff at baseline and all follow-up sessions).
Thus, this null result may be due to an overall low level of depression symptomatology in this sample. Future studies should examine this question in samples expected to have higher and more variable BDI scores (e.g., in individuals with concurrent depressive symptomatology).
Similarly, we did not find evidence of moderated mediation by neuroticism level. This finding is in contrast to a previous study that showed that individuals with higher trait negative affectivity benefited more from support counseling than those with lower negative affectivity (Zelman et al., 1992) , and it suggests that individuals with varying levels of trait negative affectivity may benefit equally from naturally occurring social support during smoking cessation. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 participants were asked to recall their smoking behavior using a timeline follow back method that covered the interval from the last assessment (i.e., 2-6 months), and future studies should include more frequent assessments to limit potential recall biases. To our knowledge, though, this study offers the first test of the stress-buffering theoretical model of social support and reveals a specific pathway by which naturally occurring social support facilitates smoking cessation (i.e., by mitigating bothersome withdrawal symptoms). These 
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